CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 133 enrolled
Drug / intervention
senofilcon A with new UV blocker +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02982018
NCT02982018N/ACompleted
CompareCT.gov

Clinical Evaluation of Approved and Investigational Contact Lenses Using New UV Additive

Johnson & Johnson Vision Care, Inc.·interventional·Posted Dec 5, 2016·Updated Jul 19, 2018

In Brief

A clinical study evaluating senofilcon A with new UV blocker and senofilcon A for Visual Acuity. Completed, enrolled 133 participants across 6 sites.

Detailed Summary

Randomized, 8-visit dispensing study over 14 weeks to evaluate the safety and efficacy of an investigational contact lens with a new UV blocker compared to a marketed contact lens.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 5, 2016
Enrollment StartOct 1, 2016
Primary CompletionFeb 18, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.6 years ago

Interventions

senofilcon A with new UV blockerdevice

Investigational Contact Lens

senofilcon Adevice

J\&J Marketed Contact Lens